title: Terbium sensitized luminescence for the determination of ketoprofen in pharmaceutical formulations.
abstract: This paper explores an ultra-sensitive luminescence method for the determination of Ketoprofen (KP) in pharmaceutical formulations. The technique is indirect and exploits the luminescence enhancement of terbium (Tb(3+)) by complexation with KP (Tb(3+)-KP), which was monitored at respective excitation and emission wavelengths of lambda(ex) = 258 nm and lambda(em) = 549 nm. The effect of varying the Tb(3+) concentration and using multiple solvents was examined to determine optimal experimental conditions. Maximum sensitization was accomplished in the presence of methanol where the most favourable condition for the formation of the complex was recorded at a level of 1.0 x 10(-5) M of Tb(3+). Under these optimum experimental conditions, linear calibration curve was obtained in the range of 2.8 x 10(-7)-3.1 x 10(-6) M with a detection limit of 8.7 x 10(-8) M. The technique was validated with 'working' reference standards and produced relative standard deviations < 2% indicating that the reproducibility was highly acceptable. The proposed method was successfully applied to assays of KP in pharmaceutical formulations with average recoveries of 92-98%. The results were found to be in good agreement with those obtained by HPLC. The method is highly suited for general applications of this nature.
authors.affiliation: Department of Chemistry, Sultan Qaboos University, College of Science, Box 36, Al-Khod 123, Muscat, Sultanate of Oman. alkindy@squ.edu.om
authors.forename: Salma M Z
authors.initials: SM
authors.lastname: Al-Kindy
authors.forename: Zakiya
authors.initials: Z
authors.lastname: Al-Harasi
authors.forename: Fakhr Eldin O
authors.initials: FE
authors.lastname: Suliman
authors.forename: Abdalla
authors.initials: A
authors.lastname: Al-Hamadi
authors.forename: Avin
authors.initials: A
authors.lastname: Pillay
mesh_terms: D002138:Calibration; D007660:Ketoprofen / Q000032:analysis*; D008163:Luminescent Measurements / Q000379:methods*; D000432:Methanol; D004364:Pharmaceutical Preparations / Q000032:analysis; D012015:Reference Standards; D013725:Terbium / Q000737:chemistry*
chemical_list: D004364:Pharmaceutical Preparations; D013725:Terbium; D007660:Ketoprofen; D000432:Methanol
references.citation: Talanta. 2004 Dec 15;64(5):1343-50
references.pmid: 18969752
references.citation: J Chromatogr A. 2005 May 6;1073(1-2):341-6
references.pmid: 15909539
references.citation: J Chromatogr A. 2005 Aug 19;1084(1-2):152-9
references.pmid: 16114248
references.citation: J Chromatogr A. 1998 Mar 13;799(1-2):301-7
references.pmid: 9550108
references.citation: Spectrochim Acta A Mol Biomol Spectrosc. 2003 Nov;59(13):3085-92
references.pmid: 14583283
references.citation: J Pharm Biomed Anal. 2007 Mar 12;43(4):1221-7
references.pmid: 17127029
references.citation: Talanta. 2003 Oct 17;61(2):221-31
references.pmid: 18969181
references.citation: J Pharm Biomed Anal. 2004 Oct 29;36(2):393-9
references.pmid: 15496335
references.citation: Biomed Chromatogr. 1997 May-Jun;11(3):137-42
references.pmid: 9192105
references.citation: Analyst. 1999 Jul;124(7):1079-84
references.pmid: 10736863
references.citation: J Pharm Biomed Anal. 2004 Nov 15;36(3):625-9
references.pmid: 15522540
references.citation: Farmaco. 2003 Jun;58(6):419-22
references.pmid: 12767380
references.citation: J Pharm Biomed Anal. 2007 Jul 27;44(3):824-8
references.pmid: 17459642
references.citation: Anal Chem. 1997 May 1;69(9):1793-9
references.pmid: 21639306
references.citation: Mol Pharmacol. 2001 Apr;59(4):901-8
references.pmid: 11259636
references.citation: Spectrochim Acta A Mol Biomol Spectrosc. 2007 Mar;66(3):676-80
references.pmid: 16859964
references.citation: J Chromatogr A. 2001 Apr 20;914(1-2):299-314
references.pmid: 11358225
references.citation: Spectrochim Acta A Mol Biomol Spectrosc. 2008 Dec 15;71(4):1461-5
references.pmid: 18586554
references.citation: J Pharm Biomed Anal. 2004 Jun 29;35(4):807-16
references.pmid: 15193725
references.citation: J Chromatogr A. 2002 Dec 27;982(2):293-301
references.pmid: 12489886
references.citation: Cancer Lett. 1999 Dec 1;147(1-2):187-93
references.pmid: 10660105
references.citation: J Pharm Biomed Anal. 2001 Feb;24(4):587-94
references.pmid: 11272315
references.citation: J Chromatogr A. 2001 Apr 20;914(1-2):211-22
references.pmid: 11358215
references.citation: J Chromatogr A. 2005 Feb 18;1065(2):279-85
references.pmid: 15782974
references.citation: Talanta. 1998 Mar;45(5):829-34
references.pmid: 18967067
references.citation: Luminescence. 2007 Jul-Aug;22(4):294-301
references.pmid: 17373027